ENST00000330775.9:c.59G>A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The ENST00000330775.9(SLC37A4):c.59G>A(p.Gly20Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G20A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000330775.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164278.2 | c.59G>A | p.Gly20Asp | missense_variant | Exon 3 of 12 | NP_001157750.1 | ||
SLC37A4 | NM_001164277.2 | c.59G>A | p.Gly20Asp | missense_variant | Exon 3 of 11 | NP_001157749.1 | ||
SLC37A4 | NM_001164280.2 | c.59G>A | p.Gly20Asp | missense_variant | Exon 1 of 9 | NP_001157752.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248896Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135064
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461454Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727014
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384
ClinVar
Submissions by phenotype
Glucose-6-phosphate transport defect Pathogenic:4
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 20 of the SLC37A4 protein (p.Gly20Asp). This variant is present in population databases (rs193302881, gnomAD 0.003%). This missense change has been observed in individual(s) with glycogen-storage disease type Ib (GSD Ib) (PMID: 9758626, 10518030, 12373566; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 68286). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC37A4 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC37A4 function (PMID: 12444104). For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: SLC37A4 c.59G>A (p.Gly20Asp) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Two of two in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.4e-05 in 276916 control chromosomes (gnomAD). c.59G>A has been reported in the literature in multiple individuals affected with Glycogen Storage Disease Type Ib and Type Ic (Veiga-da-Cunha 1998, Galli 1999, Jun 2014). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Chen 2002). The most pronounced variant effect results in <10% of normal microsomal G6P uptake activity. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
The observed missense variant c.59G>A (p.Gly20Asp) in SLC37A4 gene has been reported previously in multiple individuals affected with Glycogen storage disease Ib (Jun et al. 2014; Wortmann et al. 2020). Experimental evidence shows that this variant destabilizes the glucose-6-phosphate transporter (G6PT) activity to <10% of normal microsomal G6P uptake activity (Chen et al. 2002). The p.Gly20Asp variant is present with an allele frequency of 0.002% on gnomAD exomes database. This variant has been submitted to the ClinVar database as Likely Pathogenic / Pathogenic (multiple submissions). Computational evidence (SIFT - damaging) predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position on SLC37A4 gene is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Gly at position 20 is changed to a Asp changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:3Other:1
- -
SLC37A4: PM3:Strong, PM2, PS3:Supporting -
- -
PP3, PM2, PM3, PS3, PS4_moderate -
Glucose-6-phosphate transport defect;C0342749:Phosphate transport defect;C5561986:Congenital disorder of glycosylation, type IIw Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at